Large population study identifies drugs associated with reduced COVID-19 severity
View ORCID ProfileAriel Israel, Alejandro A. Schäffer, View ORCID ProfileAssi Cicurel, Ilan Feldhamer, Ameer Tal, View ORCID ProfileKuoyuan Cheng, Sanju Sinha, Eyal Schiff, Gil Lavie, View ORCID ProfileEytan Ruppin
doi: https://doi.org/10.1101/2020.10.13.20211953
Ariel Israel
1Division of Planning and Strategy, Clalit Health Services, Israel
M.D., Ph.D.Alejandro A. Schäffer
3Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Ph.D.Assi Cicurel
1Division of Planning and Strategy, Clalit Health Services, Israel
2Clalit Health Services, Southern District and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
M.D., M.B.A.Ilan Feldhamer
1Division of Planning and Strategy, Clalit Health Services, Israel
M.A.Ameer Tal
1Division of Planning and Strategy, Clalit Health Services, Israel
M.Sc.Kuoyuan Cheng
3Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
M.S.Sanju Sinha
3Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
B.Tech.Eyal Schiff
4Sheba Medical Center, Tel-Aviv University, Israel
MDGil Lavie
1Division of Planning and Strategy, Clalit Health Services, Israel
5Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
M.D., M.H.A., M.B.A.Eytan Ruppin
3Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
M.D., Ph.D.Article usage
Posted October 18, 2020.
Large population study identifies drugs associated with reduced COVID-19 severity
Ariel Israel, Alejandro A. Schäffer, Assi Cicurel, Ilan Feldhamer, Ameer Tal, Kuoyuan Cheng, Sanju Sinha, Eyal Schiff, Gil Lavie, Eytan Ruppin
medRxiv 2020.10.13.20211953; doi: https://doi.org/10.1101/2020.10.13.20211953
Large population study identifies drugs associated with reduced COVID-19 severity
Ariel Israel, Alejandro A. Schäffer, Assi Cicurel, Ilan Feldhamer, Ameer Tal, Kuoyuan Cheng, Sanju Sinha, Eyal Schiff, Gil Lavie, Eytan Ruppin
medRxiv 2020.10.13.20211953; doi: https://doi.org/10.1101/2020.10.13.20211953
Subject Area
Subject Areas
- Addiction Medicine (396)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12687)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4546)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2901)
- Health Policy (1067)
- Hematology (383)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4313)
- Nursing (233)
- Nutrition (633)
- Oncology (2253)
- Ophthalmology (641)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1193)
- Primary Care Research (492)
- Public and Global Health (6901)
- Radiology and Imaging (1519)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)